Latest PathoGenetix Inc. Stories
New research from PathoGenetix, Inc. demonstrates the use of its Genome Sequence Scanning technology to confirm and strain type pathogenic E.
A new protocol from PathoGenetix, Inc. enables identification and strain typing of bacteria directly from clinical stool samples in five hours, without the need for a cultured isolate.
PathoGenetix, Inc. has delivered an early commercial version of the RESOLUTION Microbial Genotyping System to the independent contract research firm, MRIGlobal.
Q Laboratories, Inc. will conduct independent testing of the RESOLUTION Microbial Genotyping System from PathoGenetix, Inc.
An independent evaluation of PathoGenetix, Inc.’s rapid bacterial strain typing technology by contract testing lab Marshfield Food Safety found greater ease-of-use and increased accuracy in
FDA has leased PathoGenetix’s RESOLUTION Microbial Genotyping System to assess the effectiveness of the proprietary bacterial strain typing system in identifying pathogens involved in foodborne
PathoGenetix has signed Sparton for manufacturing design and pilot production of its rapid bacterial identification and strain typing system.
A new agreement between Marshfield Food Safety, LLC, and PathoGenetix, Inc., provides for independent testing of the RESOLUTION Microbial Genotyping System for use in pathogen confirmation and
PathoGenetix, Inc., has completed an initial round of evaluations for its RESOLUTION Microbial Genotyping System with leading contract testing laboratories serving the food safety market.